menu
    • menu

    Company profile for Heron Therapeutics

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Our mission is to improve the lives of patients by developing novel, best-in-class treatments to address some of the most important unmet patient needs. We aim to develop patient-focused solutions by applying our innovative science and technologies with well-known pharmacology. Heron Therapeutics is committed to supporting programs and activities that inspire best-in-class patient care, medical and scientific education, and pa...
    Our mission is to improve the lives of patients by developing novel, best-in-class treatments to address some of the most important unmet patient needs. We aim to develop patient-focused solutions by applying our innovative science and technologies with well-known pharmacology. Heron Therapeutics is committed to supporting programs and activities that inspire best-in-class patient care, medical and scientific education, and patient advocacy. In alignment with our goals to develop best-in-class medicines for the management of cancer and pain, Heron is focused on initiatives related to the areas of oncology.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Heron TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    4242 Campus Point Court, Suite 200 San Diego, CA 92121
    Telephone
    Telephone
    858-251-4400
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.herontx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/heron-therapeutics-inc-
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Heron Adopts Plan to Protect NOL Assets, Shareholder Value
    Heron Adopts Plan to Protect NOL Assets, Shareholder Value

    15 Aug 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/heron-therapeutics-inc-adopts-tax-benefits-preservation-plan-to-protect-nol-assets-and-shareholder-value-302530819.html

    PR NEWSWIRE
    15 Aug 2025
    Share Share
    Heron Therapeutics Reports Q2 2025 Financial Results, Progress
    Heron Therapeutics Reports Q2 2025 Financial Results, Progress

    08 Aug 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/heron-therapeutics-announces-q2-2025-financial-results-and-highlights-commercial-progress-302525114.html

    PR NEWSWIRE
    08 Aug 2025
    Share Share
    Heron Therapeutics Restructures Capital for Growth
    Heron Therapeutics Restructures Capital for Growth

    08 Aug 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/heron-therapeutics-announces-comprehensive-capital-restructuring-to-support-growth-and-extend-maturity-profile-302525116.html

    PR NEWSWIRE
    08 Aug 2025
    Share Share
    Heron Therapeutics' Q2 2025 Financial Results Due August 11
    Heron Therapeutics' Q2 2025 Financial Results Due August 11

    28 Jul 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/heron-therapeutics-to-report-second-quarter-2025-financial-results-on-monday-august-11-2025-302515450.html

    PR NEWSWIRE
    28 Jul 2025
    Share Share
    Heron Therapeutics Appoints Mark Hensley as COO
    Heron Therapeutics Appoints Mark Hensley as COO

    28 Apr 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/heron-therapeutics-announces-appointment-of-mark-hensley-as-chief-operating-officer-302440350.html

    PR NEWSWIRE
    28 Apr 2025
    Share Share
    Heron Therapeutics to Report Q4 & Full Year 2024 Financial Results
    Heron Therapeutics to Report Q4 & Full Year 2024 Financial Results

    13 Feb 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/heron-therapeutics-to-report-fourth-quarter-and-full-year-2024-financial-results-on-thursday-february-27-2025-302376545.html

    PR NEWSWIRE
    13 Feb 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search